Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
2.860
-0.030 (-1.04%)
At close: Oct 2, 2026, 4:00 PM EDT
2.850
-0.010 (-0.35%)
After-hours: Oct 2, 2026, 7:30 PM EDT
Entera Bio Employees
As of June 30, 2026, Entera Bio had 22 total employees, including 20 full-time and 2 part-time employees. The number of employees increased by 1 or 4.76% compared to the same quarter last year.
Employees
22
Change
1
Growth
4.76%
Revenue / Employee
n/a
Profits / Employee
-$774,227
Market Cap
495.19M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 22 | 1 | 4.76% | 20 | 2 |
| Mar 31, 2026 | 22 | 2 | 10.00% | 20 | 2 |
| Dec 31, 2025 | 22 | 2 | 10.00% | 20 | 2 |
| Sep 30, 2025 | 22 | 2 | 10.00% | 20 | 2 |
| Jun 30, 2025 | 21 | 2 | 10.53% | 19 | 2 |
| Mar 31, 2025 | 20 | 1 | 5.26% | 18 | 2 |
| Dec 31, 2024 | 20 | 2 | 11.11% | 18 | 2 |
| Sep 30, 2024 | 20 | -1 | -4.76% | 18 | 2 |
| Jun 30, 2024 | 19 | -2 | -9.52% | 17 | 2 |
| Mar 31, 2024 | 19 | 1 | 5.56% | 17 | 2 |
| Dec 31, 2023 | 18 | 1 | 5.88% | 17 | 1 |
| Sep 30, 2023 | 21 | 2 | 10.53% | 19 | 2 |
| Jun 30, 2023 | 21 | -1 | -4.55% | 19 | 2 |
| Mar 31, 2023 | 18 | -3 | -14.29% | 18 | 0 |
| Dec 31, 2022 | 17 | -3 | -15.00% | 15 | 2 |
| Sep 30, 2022 | 19 | -4 | -17.39% | 19 | 0 |
| Jun 30, 2022 | 22 | 3 | 15.79% | 22 | 0 |
| Mar 31, 2022 | 21 | 2 | 10.53% | 21 | 0 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| REGENXBIO | 371 |
| Arvinas | 246 |
| ProKidney | 231 |
| Capricor Therapeutics | 231 |
| Puma Biotechnology | 179 |
| Assembly Biosciences | 73 |
| AgomAb Therapeutics NV | 62 |
ENTX News
- 8 days ago - Guggenheim starts Entera with Buy on N-tab platform potential - TheFly
- 9 days ago - Entera Bio initiated with a Buy at Guggenheim - TheFly
- 10 days ago - Entera Bio Proxy statement: Proxy filing - Filings
- 10 days ago - Entera Bio initiated with an Outperform at LifeSci Capital - TheFly
- 11 days ago - Entera Bio initiated with an Overweight at Cantor Fitzgerald - TheFly
- 11 days ago - Entera Bio initiated with an Overweight at Cantor Fitzgerald - TheFly
- 15 days ago - Leerink bullish on Entera Bio, initiates with an Outperform - TheFly
- 15 days ago - Entera Bio initiated with an Outperform at Leerink - TheFly